Kirsch, Brandon, Janet DuBois, and Deepak Chadha. “A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, With Axillary Hyperhidrosis”. SKIN The Journal of Cutaneous Medicine 3 (November 9, 2019): S54. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/782.